Is levofloxacin as active as ciprofloxacin against Pseudomonas aeruginosa?

Chemotherapy

Volumn 47, Issue 4, 2001, Pages 239-242

  Bonfiglio, Giovanni ^a  

^a UNIVERSITY OF CATANIA   (Italy)

Author keywords

In vitro activity; Levofloxacin; Pseudomonas aeruginosa; Quinolones

Indexed keywords

AMIKACIN; CEFTAZIDIME; CIPROFLOXACIN; IMIPENEM; LEVOFLOXACIN; OFLOXACIN; PIPERACILLIN;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERICIDAL ACTIVITY; BACTERIUM ISOLATION; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA;

ANTI-INFECTIVE AGENTS; CIPROFLOXACIN; CROSS INFECTION; DRUG EVALUATION, PRECLINICAL; HUMANS; OFLOXACIN; PSEUDOMONAS AERUGINOSA;

EID: 0034950551     PISSN: 00093157     EISSN: None     Source Type: Journal    
DOI: 10.1159/000048529     Document Type: Article

References (10)

1. Predominant pathogens in hospital infections
2. Susceptibility survey of piperacillin/tazobactam and some β-lactam comparators in Italy
3. Levofloxacin. A review of its antibacterial activity, pharmacokinetis and therapeutic efficacy
4. Mechanism of differential activities of ofloxacin enantiomers
5. Italian survey on comparative levofloxacin susceptibility in 334 clinical isolates of Pseudomonas aeruginosa
6. Antibiotic resistance in Pseudomonas aeruginosa: An Italian survey
7. Levofloxacin in-vitro activity and time-kill evaluation of Stenotrophomonas maltophilia clinical isolates
8. Role of efflux pump(s) in intrinsic resistance of Pseudomonas aeruginosa: Active efflux as a contributing factor to β-lactam resistance
9. Bactericidal index: A new way to assess quinolone bactericidal activity in vitro